TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 42.9 -0.10 (-0.23%) Aug 6
18.07
P/B:
12.55
Market Cap:
€ 6.56B ($ 7.56B)
Enterprise V:
€ 6.73B ($ 7.77B)
Volume:
131.00
Avg Vol (2M):
161.00
Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (STU:NKB2) Operating Data Charts